Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Subscribe to JNMT RSS feeds
Research ArticleImaging

18F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer

Naghmehossadat Eshghi, Linda L. Garland, Emily Nia, Robert Betancourt, Elizabeth Krupinski and Phillip H. Kuo
Journal of Nuclear Medicine Technology September 2018, 46 (3) 260-264; DOI: https://doi.org/10.2967/jnmt.117.204933
Naghmehossadat Eshghi
1Department of Medical Imaging, Banner University Medical Center, Tucson, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda L. Garland
2Department of Medicine, Section of Hematology and Medical Oncology, Banner University Medical Center, Tucson, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily Nia
3Breast Imaging Section, Department of Radiology, University of Texas M.D. Anderson Cancer Center, Housten, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Betancourt
4Department of Medicine, Banner University Medical Center, Tucson, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Krupinski
5Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phillip H. Kuo
6Departments of Medical Imaging and Medicine, Banner University Medical Center, and Department of Biomedical Engineering, University of Arizona, Tucson, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 46 no. 3 260-264
DOI 
https://doi.org/10.2967/jnmt.117.204933
PubMed 
29599403

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication November 13, 2017
  • Accepted for publication January 4, 2018
  • Published online September 6, 2018.

Article Versions

  • previous version (March 29, 2018 - 14:51).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Naghmehossadat Eshghi1,
  2. Linda L. Garland2,
  3. Emily Nia3,
  4. Robert Betancourt4,
  5. Elizabeth Krupinski5 and
  6. Phillip H. Kuo6
  1. 1Department of Medical Imaging, Banner University Medical Center, Tucson, Arizona
  2. 2Department of Medicine, Section of Hematology and Medical Oncology, Banner University Medical Center, Tucson, Arizona
  3. 3Breast Imaging Section, Department of Radiology, University of Texas M.D. Anderson Cancer Center, Housten, Texas
  4. 4Department of Medicine, Banner University Medical Center, Tucson, Arizona
  5. 5Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia; and
  6. 6Departments of Medical Imaging and Medicine, Banner University Medical Center, and Department of Biomedical Engineering, University of Arizona, Tucson, Arizona
  1. For correspondence or reprints contact: Naghmehossadat Eshghi, Department of Medical Imaging, Banner University Medical Center, 1501 N. Campbell Ave., P.O. Box 245067, Tucson, AZ 85724. E-mail: neshghi{at}radiology.arizona.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 27 Citations
  • 30 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Can benign lymphoid tissue changes in 18F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?
    Christos Sachpekidis, Lionel Larribère, Annette Kopp-Schneider, Jessica C. Hassel, Antonia Dimitrakopoulou-Strauss
    Cancer Immunology, Immunotherapy 2019 68 2
  • FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls
    Steve Y. Cho, Daniel T. Huff, Robert Jeraj, Mark R. Albertini
    Seminars in Nuclear Medicine 2020 50 6
  • Impact of PET/CT for Assessing Response to Immunotherapy—A Clinical Perspective
    David Lang, Gerald Wahl, Nikolaus Poier, Sebastian Graf, David Kiesl, Bernd Lamprecht, Michael Gabriel
    Journal of Clinical Medicine 2020 9 11
  • Reassessing Patterns of Response to Immunotherapy with PET: From Morphology to Metabolism
    Larissa B. Costa, Marcelo A. Queiroz, Felipe G. Barbosa, Rafael F. Nunes, Elaine C. Zaniboni, Mariana Mazo Ruiz, Denis Jardim, Jose Flavio Gomes Marin, Giovanni G. Cerri, Carlos A. Buchpiguel
    RadioGraphics 2021 41 1
  • PET/CT and the Response to Immunotherapy in Lung Cancer
    Laura Evangelista, Matteo Sepulcri, Giulia Pasello
    Current Radiopharmaceuticals 2020 13 3
  • Application of molecular imaging technology in tumor immunotherapy
    Yiming Meng, Jing Sun, Na Qv, Guirong Zhang, Tao Yu, Haozhe Piao
    Cellular Immunology 2020 348
  • NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images
    Virginia Liberini, Annapaola Mariniello, Luisella Righi, Martina Capozza, Marco Donatello Delcuratolo, Enzo Terreno, Mohsen Farsad, Marco Volante, Silvia Novello, Désirée Deandreis
    Cancers 2021 13 18
  • PET/CT metabolic patterns in systemic immune activation: A new perspective on the assessment of immunotherapy response and efficacy
    Peng Jin, Jianing Li, Yingtao Meng, Leilei Wu, Menglin Bai, Jinming Yu, Xue Meng
    Cancer Letters 2021 520
  • Detection of thyroiditis on PET/CT imaging: a systematic review
    Domenico Albano, Giorgio Treglia, Luca Giovanella, Raffaele Giubbini, Francesco Bertagna
    Hormones 2020 19 3
  • Biomarkers and risk factors for the early prediction of immune-related adverse events: a review
    Ying Zhang, Xiaoling Zhang, Weiling Li, Yunyi Du, Wenqing Hu, Jun Zhao
    Human Vaccines & Immunotherapeutics 2022 18 1

Article usage

Article usage: March 2018 to February 2023

AbstractFullPdf
Mar 20182101
Apr 201818309
May 20186301
Jun 20185701
Jul 20185802
Aug 20186403
Sep 2018238210
Oct 2018218211
Nov 201815435
Dec 20186816
Jan 20197913
Feb 20197445
Mar 20197310
Apr 20194845
May 20193203
Jun 20193102
Jul 20194004
Aug 20193803
Sep 2019482327
Oct 2019562027
Nov 2019904544
Dec 2019341321
Jan 2020612513
Feb 2020632125
Mar 2020815121
Apr 2020511819
May 2020643021
Jun 2020491716
Jul 2020442711
Aug 202023107
Sep 2020351722
Oct 2020341910
Nov 202036913
Dec 2020151813
Jan 2021111522
Feb 2021212327
Mar 2021132619
Apr 202172212
May 2021172825
Jun 2021103214
Jul 202192423
Aug 202184013
Sep 202120148
Oct 202193338
Nov 2021163428
Dec 2021123211
Jan 202293215
Feb 2022164123
Mar 202243728
Apr 202244117
May 202291915
Jun 202272416
Jul 20226263
Aug 202221816
Sep 2022103014
Oct 202262336
Nov 202232121
Dec 202282311
Jan 20237159
Feb 20237258
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 46 (3)
Journal of Nuclear Medicine Technology
Vol. 46, Issue 3
September 1, 2018
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
18F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer
Naghmehossadat Eshghi, Linda L. Garland, Emily Nia, Robert Betancourt, Elizabeth Krupinski, Phillip H. Kuo
Journal of Nuclear Medicine Technology Sep 2018, 46 (3) 260-264; DOI: 10.2967/jnmt.117.204933

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer
Naghmehossadat Eshghi, Linda L. Garland, Emily Nia, Robert Betancourt, Elizabeth Krupinski, Phillip H. Kuo
Journal of Nuclear Medicine Technology Sep 2018, 46 (3) 260-264; DOI: 10.2967/jnmt.117.204933
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Improving 90Y PET Scan Image Quality Through Optimized Reconstruction Algorithms
  • Evaluation of Data-Driven Respiration Gating in Continuous Bed Motion in Lung Lesions
  • Optimization of the Attenuation Coefficient for Chang Attenuation Correction in 123I Brain Perfusion SPECT
Show more Imaging

Similar Articles

Keywords

  • Molecular Imaging
  • Oncology: Lung
  • PET/CT
  • 18F-FDG-PET/CT
  • Immunotherapy
  • lung cancer
  • Thyroiditis
SNMMI

© 2023 Journal of Nuclear Medicine Technology

Powered by HighWire